USA
FDA Approves a New Non-Opioid Therapy for Acute Pain
The U.S. Food and Drug Administration has officially approved for Journavx (suzetrigine) 50 mg oral tablets, marking the introduction...
VISTAAR provides Global regulatory submission requirements, guidance documents, updates, news and other regulatory details to Biopharma, Medical Devices, Digital Health, Diagnostics, Consumer Health...